检索结果 - Chengqiang Li
- Showing 1 - 5 results of 5
-
1
-
2
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy... 由 Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao, Hecheng Li
出版 2023Artigo -
3
Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy: Short-term Results of a Randomized Clinical Trial (RVlob Trial). 由 Runsen Jin, Yuyan Zheng, Ye Yuan, Dingpei Han, Yuqin Cao, Yajie Zhang, Chengqiang Li, Jie Xiang, Zhengyuan Zhang, Zhenyi Niu, Antoon Lerut, Jules Lin, Abbas E. Abbas, Alessandro Pardolesi, Takashi Suda, Dario Amore, Stefan Schraag, Clemens Aigner, Jian Li, Jiaming Che, Junbiao Hang, Jian Ren, Lianggang Zhu, Hecheng Li
出版 2022Artigo -
4
Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy 由 Runsen Jin, Yuyan Zheng, Ye Yuan, Dingpei Han, Yuqin Cao, Yajie Zhang, Chengqiang Li, Jie Xiang, Zhengyuan Zhang, Zhenyi Niu, Antoon Lerut, Jules Lin, Abbas E. Abbas, Alessandro Pardolesi, Takashi Suda, Dario Amore, Stefan Schraag, Clemens Aigner, Jian Li, Jiaming Che, Junbiao Hang, Jian Ren, Lianggang Zhu, Hecheng Li
出版 2021Artigo -
5
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial 由 Jianjun Qin, Liyan Xue, Anlin Hao, Xiaofeng Guo, Tao Jiang, Yunfeng Ni, Shuoyan Liu, Yujie Chen, Hongjing Jiang, Chen Zhang, Mingqiang Kang, Jihong Lin, Hecheng Li, Chengqiang Li, Hui Tian, Lin Li, Junke Fu, Yong Zhang, Jianqun Ma, Xiaoyuan Wang, Maoyong Fu, Hao Yang, Zhaoyang Yang, Yongtao Han, Long-Qi Chen, Lijie Tan, Tianyang Dai, Yongde Liao, Weiguo Zhang, Bin Li, Qixun Chen, Guo Shiping, Yu Qi, Li Wei, Zhigang Li, Ziqiang Tian, Xiaozheng Kang, Ruixiang Zhang, Yong Li, Zhen Wang, Xiankai Chen, Zhiguo Hou, Rongrong Zheng, Wenqing Zhu, Jie He, Yin Li
出版 2024Artigo
相关主题
Internal medicine
Medicine
Cancer
Oncology
Perioperative
Randomized controlled trial
Surgery
Breast cancer
Chemotherapy
Interquartile range
Neoadjuvant therapy
Adenocarcinoma
Anesthesia
Basal cell
Carcinoma
Chemoradiotherapy
Clinical trial
Cohort
Esophageal adenocarcinoma
Esophageal squamous cell carcinoma
Esophagogastric junction
Gastroenterology
Immunotherapy
Lymphocyte
Multivariate analysis
Pembrolizumab
Proportional hazards model
Prospective cohort study
Surgical oncology
Trial registration